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Theranostics are emerging platforms for rapid cancer diagnosis and therapy. Hybrid iron oxide–gold
nanoparticles (HNPs) have shown potential as theranostics due to their ability for imaging using MRI,
heating using laser irradiation and carrier abilities for drug molecules after surface functionalization. The
ability of HNPs to act as localised nano-heaters has been well documented for tumour ablation
applications where maximal heating eﬀect is desired. However, the use of HNPs as thermal triggers for
drug release requires more control over temperature output and careful consideration of heat
dissipation. In this work we report the potential of HNPs to act as localised nano-heaters in vitro and
document the cellular eﬀect prior and post laser irradiation in human pancreatic adenocarcinoma
(BxPC-3) cell lines. The data showed that after incubation of 50 mg mL1 HNPs, a thermal increase of up
to 9 C was observed in the cells after laser irradiation with the total area experiencing heat dissipation
from the laser beam being 346 mm2. Although the total temperature experienced by cells was below the
perceived temperature for irreversible cell damage, after 24 h signiﬁcant levels of HSP27 and HSP70
were evident with a drop in cell viability to 85%. This indicated that even with rapid irradiation at low
temperatures the cells were undergoing stress. Upon I.T. injection in pancreatic xenograft models,
a similar heating capacity was observed at identical concentration which also resulted in bulk tumour
dissipation. The ﬁndings from this work highlight the factors which must be taken into consideration
when designing HNPs as theranostics for heat triggered drug delivery.1. Introduction
Of all cancers, pancreatic cancer is the fourth biggest killer in
the western world, with less than 34% of patients surviving 5
years aer diagnosis.1 Late diagnosis and treatment reduces the
probability of successfully treating the cancer. Oen, a delay
between diagnosis and treatment exacerbates this. The gold
standard treatment for pancreatic cancer is the use of gemci-
tabine (2,2-diuorodeoxycytidine).2 Gemcitabine is a nucleoside
analogue that mimics physiological nucleosides in terms of
uptake and metabolism and is incorporated into newly syn-
thesised DNA resulting in synthesis inhibition and chain
termination. Unfortunately, this chemotherapeutic agent
proves eﬀective in only 23.8% of patients with the only alter-
native being surgical removal of the localised tumour.3
The treatment of pancreatic adenocarcinomas is oen
hindered by a lack of drug penetration through the dense
stroma of the solid tumours formed.4 In order to overcome this
problem, higher drug doses are increasingly required in orderMedicine, School of Pharmacy, Keele
.hoskins@keele.ac.uk; Tel: +44 (0)1782
ciences, Keele University, Keele, ST5 5BG,
54to attain a therapeutic eﬀect. As a result, patients experience
a greater degree and extent of side eﬀects such as increased risk
of infection, bruising and bleeding, anaemia, nausea, breath-
lessness, renal or hepatic impairment, hair loss and tiredness.5
These side eﬀects result from the systemic circulation of the
toxic drug agents and their lack of specicity. Nanotechnology
is increasingly being exploited for use in cancer therapy with
formulations such as Abraxane® and Onivyde® gaining regu-
latory approval in the last ve years.6 The use of nanotechnology
is favoured in cancer therapy due to the unique properties of
particulates at this size range,7 diversity of architecture and
compositions,8 ease of synthesis9 and their ability to passively
target cancerous vasculature resulting in deeper tissue perme-
ation via the enhanced permeability and retention eﬀect.10
Advances in nanotechnology for cancer therapy has led to the
development of multifunctional entities known as theranostics.
Theranostics are platforms which oﬀer simultaneous diag-
nosis and therapy, resulting in decreased treatment times.11
These theranostic agents allow for real time imaging aer
administration, enabling location mapping before initiating
therapeutic eﬀect (e.g. ablation/drug release/combination). By
coupling treatments to diagnostics and controlling drug
release, a rapid and localised clinical eﬀect can be achieved.
Early diagnosis in disease states such as pancreatic cancer canThis journal is © The Royal Society of Chemistry 2016
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View Article Onlinemean the diﬀerence between life and death. Many types of
theranostics have been reported using both organic and inor-
ganic nanoparticulates.12 One class of theranostic agents which
has shown potential due to its chemical and physical stability,
ease of synthesis and scope for further functionalisation are
hybrid nanoparticles.13
Hybrid nanoparticles consisting of an iron oxide core sur-
rounded by a gold shell have shown great promise in cancer
therapy.14 Their ability to act as T2 contrast agents for MRI
imaging arising from their magnetic iron oxide core and to act
as both nano-heaters15 and drug carriers aer surface func-
tionalisation of the gold shell has been reported previously.14,16
The use of HNPs as carriers for anticancer agents attached onto
the gold surface via linker molecules or with the exploitation of
thiol–gold chemistry has been reported.14,16 Wagstaﬀ et al. re-
ported the conjugation of cisplatin onto the surface of HNPs.15
The cisplatin was conjugated through a thiolated polyethylene
glycol (PEG) linker. The HNPs produced showed low inherent
cytotoxicity on ovarian cancer cell lines (A2780 and A2780/cp70),
however the cisplatin conjugated HNPs exhibited up to a 110-
fold more cytotoxic eﬀect than the free drug.16 Other studies
have been focused on the use of HNPs as drug carriers for
pancreatic cancer therapy. Barnett et al. studied the attachment
of cytotoxic agent 6-thioguanine (6-TG) onto HNPs.14 In this
study, the HNP–6-TG formulation exhibited a 10-fold decrease
IC50 in comparison with the free drug in human pancreatic
adenocarcinoma (BxPC-3 cells).14
Colloidal gold undergoes surface plasmon resonance (SPR)
when irradiated with light of a specic wavelength resulting in
the rapid conversion of absorbed light into heat energy.17 The
absorbed light energy is rapidly transformed into thermal
energy due to the delocalised electrons in the gold shell
promoting an increase in temperature; in eﬀect, acting as
a localised heating source.18 Hence these HNPs possess the
potential to act as nano-heaters for tumour ablation or stimuli
responsive drug release.
Studies have highlighted the use of HNPs in thermal abla-
tion of pancreatic cancer. Guo et al. reported cell viability
reduction as high as 97.7%, 24 h aer irradiation of GoldMag®
particles incubated inside human pancreatic (PANC-1) cells.19
Other work has reported the advantages of dual heating HNPs
through both laser irradiation and magnetic hyperthermia.20
Espinosa et al. documented the amplication of heating expe-
rienced by the HNPs was 15-fold compared with magnetic
stimulation only for tumour ablation application. This was
tested both in vitro in SKOV3, PC3, and A431 cells lines and in
vivo in xenogra skin cancer models.20
The use of HNPs for thermo-responsive drug delivery is now
a major focus. This technology benets from magnetic prop-
erties, reduced toxicities and the ability to target the drug
release using focused laser irradiation. Previously we reported
the controllable heating capacity and resultant dissipation aer
irradiation of HNPs in agar phantoms at varied concentra-
tions.21 These studies suggested that the HNPs used (50 nm)
would be useful for stimuli responsive drug release as their
heating could be controlled via alteration of irradiation time
and concentration. In order for HNPs to be used to thermallyThis journal is © The Royal Society of Chemistry 2016trigger drug release it is important that their temperature rise is
not suﬃcient to cause any thermal degradation of drug or
widespread heat dissipation at high temperatures which would
aﬀect healthy tissue. As such, for use as a drug carrier and not
an ablation agent, it is important that only localised heating is
experienced and that any temperatures experienced are not
high enough to dissipate away from the tumour site causing
unnecessary damage. It is postulated that use of HNPs, which
heat up (the bulk) to a maximal temperature below the
temperature at which irreversible damage is caused to the cells
which is approximately 50 C, will result in a system that will be
most eﬀective.
Studies on the thermal potential and heat dissipation of
HNPs for stimuli responsive drug delivery have been reported,
however the majority of these have been either been carried out
using computer modelling22 or in the use of agar phantoms21,23
and little studies have shown heating abilities aer cellular
internalization. Whilst gel phantoms are designed to mimic
physiological tissue there is an increasing need to fully under-
stand the heating ability and eﬀect on surroundings experi-
enced aer irradiation in more realistic conditions either in
vitro or in vivo.
In this study the potential of HNPs to act as thermal triggers
for drug release is evaluated in vitro using human pancreatic
adenocarcinoma cells. The rate of thermal increase and heat
dissipation away from the irradiation site will be investigated as
well as the eﬀect of HNPs on cells prior to and post irradiation.
Additionally the heating eﬀect in solid pancreatic tumours will
be mapped post mortem aer intratumoural administration in
xenogra models.
2. Experimental
2.1 Materials
All chemicals unless otherwise stated were purchased from
Sigma Aldrich (UK) and all solvents from Fisher Scientic (UK).
2.2 Imaging of HNPs using transmission electron
microscopy
HNP suspensions (50 mg mL1, 2 mL) were dried onto formvar
coated copper grids. The grids were imaged using a JEOL JEM-
1230 microscope (Jeol, Japan) using anaLYSIS soware.
2.3 Quantication of cellular uptake of HNPs in BxPC-3 cells
BxPC-3 cells were seeded into 6-well plates (50 000 cells per well)
and incubated at 37 C with 5% CO2. HNPs (5 mg mL
1 & 50 mg
mL1) were incubated with the cells for 24 h. Cells were washed
with phosphate buﬀered saline (PBS) four times and trypsi-
nised. Cells were resuspended (1 000 000 mL1) in fresh RPMI
media supplemented with 10% foetal bovine serum and 1%
penicillin streptomycin (Thermosher, UK). The cell suspen-
sion (1 mL) was placed into an Eppendorf tube and centrifuged
at 1000 rpm for 10 min. The supernatant was discarded and the
cells were resuspended in 1 mL of concentrated nitric acid. The
solutions were incubated at 90 C for 1 h before dilution in
deionised water. The iron (Fe) content was determined usingRSC Adv., 2016, 6, 95044–95054 | 95045
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View Article Onlineinductively coupled plasma-optical emission spectroscopy (ICP-
OES), compared against a calibration of known standards (R2 ¼
0.999) and the amount of iron internalised was calculated per
cell.
2.4 Imaging cellular uptake of HNPs using transmission
electron microscopy
Cellular internalisation images were taken aer incubation of
HNPs with BxPC-3 cells. Cells were grown onto Aclar slides and
incubated with HNP (5 mg mL1 & 50 mg mL1) for 24 h. Cells
were washed with PBS and xed with 2.5% glutaraldehyde in 0.1
M sodium cacodylate buﬀer : 2 mM calcium chloride (50 : 50)
for 2 h. The samples were washed for 5 min in 0.1 M sodium
cacodylate buﬀer : 2 mM calcium chloride and this step was
repeated a three times. The samples were post xed in 0.1%
osmium tetroxide in 0.1 M sodium cacodylate buﬀer/2 mM
calcium chloride for 1 h. A dehydration series was carried out
using ethanol before the samples were embedded in spurr
resin. The samples were sectioned using a freshly cut diamond
knife and placed onto formvar coated copper grids for imaging.
The samples were imaged using a JEOL JEM-1230 microscope
(Jeol, Japan) using anaLYSIS soware.
2.5 Cellular response to HNP exposure using BxPC-3 cells
2.5.1 Cell membrane integrity. Membrane integrity was
measured via quantication of lactate dehydrogenase (LDH)
leakage using a CytoTox-ONE™ assay (Promega, UK) on BxPC-3
cells. Cells were seeded into 6-well plates (50 000 cells per well)
and incubated for 24 h. HNPs were incubated with cells (5–500
mg mL1) for 1, 24, 48 & 72 h at 37 C and 5% CO2. Aer incu-
bation, 2 mL of lysis buﬀer was added to the positive control
wells, and the plate was centrifuged at 1500 rpm for 10min at 37
C. Aer centrifugation, 50 mL of the supernatant was removed
from each well and placed into a new plate, and 50 mL of
a membrane integrity assay reagent was added to the wells. The
plates were incubated for 10 min at 37 C in the dark. Stop
reagent (25 mL) was added to the wells, and the LDH levels were
recorded at excitation wavelength 560 nm & emission wave-
length 590 nm, using a Tecan Pro200 microplate reader (Tecan,
UK). The percentage of cytotoxicity was calculated in respect to
control wells containing no nanoparticles.
2.5.2 Cell viability. BxPC-3 cells were seeded into 6-well
plates (50 000 cells per well) and incubated for 24 h. HNPs were
incubated with cells (5–500 mg mL1) for 1, 24, 48 & 72 h at 37 C
and 5% CO2. Cells were washed with PBS and trypsinised and
resuspended in 1 mL fresh media. Cell suspension (50 mL) was
mixed with 50 mL trypan blue solution for 1 min. Cells were
counted using a Countess® automated cell counter (Thermo-
sher, UK). Cell viability was determined in respect to control
cells with no nanoparticles present.
2.6 Investigation into heat generation and dissipation of
HNPs in vitro
BxPC-3 cells were seeded into 6-well plates (50 000 cells per well)
containing quartz coverslips (Alfa Aesar, USA) and incubated at
37 C with 5% CO2. HNPs (5 mg mL
1 & 50 mg mL1) were95046 | RSC Adv., 2016, 6, 95044–95054incubated with the cells for 24 h. The cells were washed with
phosphate buﬀered saline (PBS) four times and the coverslips
were removed from the plate. The cells were irradiated at 1064
nm using aML-LASER-YB5 Q-switched Nd:YAG Laser Treatment
System (WeiFang MingLiang Electronics Company Ltd., China).
Pulse width: 10 ns, pulse repetition frequency: 6 Hz, laser spot
diameter: 3 mm, cooling system: water cooled with airow
cooling. The beam was collimated through concave lenses to a 1
mm diameter and passed through the cell sample. The cells
were irradiated for 60 seconds and their changing temperature
(DT) was monitored using Optris PI640 Thermal Imaging
Camera (Optris, Germany). The camera was positioned 5 cm
away from the cells and focussed on the irradiation site. The
data was recorded on Optris PI Connect soware (Optris, Ger-
many). Data samples were recorded every 0.1 second and data
analysis was carried out oﬄine using direct measurement of the
.vga les collected. The DT was calculated as per eqn (1):
DT ¼ (Tfinal  Tinitial)  TD control (1)
Heat dissipation of the samples was measured using pixel
analysis oﬄine with optical resolution of 640  480 pixel. Eﬀect
of multiple irradiation cycles on cellular heating was investi-
gated using 60 seconds irradiation and 60 second cooling cycles
repeated over 600 seconds and monitored as above.
2.7 Measurement of heat shock protein production aer
laser irradiation
BxPC-3 cells were seeded into a quartz 96-well plate (Alfa Aesar,
USA) (15 000 cells per well) and incubated at 37 C with 5% CO2.
HNPs (5 mg mL1 & 50 mg mL1) were incubated with the cells
for 24 h. Cells were washed with phosphate buﬀered saline
(PBS) four times and the liquid aspirated from the wells. The
cells were irradiated at 1064 nm as previously described for 60
seconds. Aer irradiation fresh cell culture medium (100 mL)
was placed into the wells and the plate was incubated for 24 h.
2.7.1 HSP27. Heat shock protein 27 (HSP27 (total))
production was measured using an ELISA kit (Thermosher,
UK). Briey, 50 mL of standards and samples (cell lysates) were
added to the 96-well immunoassay plate along with 50 mL Hu
HSP (total) detection antibody. The plate was incubated at room
temperature for 2 h. Aer this time the wells were washed four
times with wash buﬀer. Anti-rabbit IgG HRP (100 mL) was added
to the wells and the plate incubated for 0.5 h at room temper-
ature. The plate was washed with buﬀer a further four times
before 100 mL stabilized chromogen was added to the wells. The
plate was incubated at room temperature in the dark for 0.5 h
aer which time 100 mL of stop solution was added to each well.
The absorbance of each well was measured at 450 nm using
a Tecan Pro200 microplate reader (Tecan, UK). The levels of
HSP27 produced in the irradiated cells was calculated in respect
to control cells with no nanoparticles.
2.7.2 HSP70. Heat shock protein 70 (HSP70) production
was measured using an ELISA kit (Enzo, USA). Briey, 100 mL of
standards and samples (cell lysates) were added to the 96-well
immunoassay plate along with 50 mL Hu HSP (total) detection
antibody. The plate was incubated at room temperature for 2 h.This journal is © The Royal Society of Chemistry 2016
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View Article OnlineAer this time the wells were washed four times with wash
buﬀer. HSP70 antibody (100 mL) was added to the wells and the
plate incubated for 1 h at room temperature. The plate was
washed with buﬀer a further four times before 100 mL HSP70
conjugate was added to the wells. The plate was incubated at
room temperature for 1 h aer which time the wells were
washed a further four times with wash buﬀer. TMB substrate
(100 mL) was added to the wells and incubated for 0.5 h before
addition of 100 mL of stop solution. The absorbance of each well
was measured at 450 nm using a Tecan Pro200 microplate
reader (Tecan, UK). The levels of HSP70 produced in the irra-
diated cells was calculated in respect to control cells with no
nanoparticles.
2.8 Cytotoxicity aer laser irradiation
BxPC-3 cells were seeded into 6-well plates (50 000 cells per well)
containing quartz coverslips (Alfa Aesar, USA) and incubated at
37 C with 5% CO2. HNPs (5 mg mL
1 & 50 mg mL1) were
incubated with the cells for 24 h. Cells were washed with
phosphate buﬀered saline (PBS) four times. The coverslips were
removed from the wells and cells were irradiated at 1064 nm as
previously described (60 seconds and multiple irradiation
cycles). Aer irradiation the coverslips were placed back into the
wells and fresh media was added and the cells were incubated
for 24 h. Aer this time the cytotoxicity was measured using
trypan blue exclusion as previously described. Cytotoxicity was
measured in relation to control cells with no nanoparticles.
2.9 Detection of apoptosis via measurement of caspase-3
activity aer laser irradiation
BxPC-3 cells were seeded into 6-well plates (50 000 cells per well)
containing quartz coverslips (Alfa Aesar, USA) and incubated at
37 C with 5% CO2. HNPs (5 mg mL
1 & 50 mg mL1) were incu-
bated with the cells for 24 h. Cells were washed with phosphate
buﬀered saline (PBS) four times. The coverslips were removed
from the wells and cells were irradiated at 1064 nm as previously
described (60 seconds and multiple irradiation cycles). Aer
irradiation the coverslips were placed into the 6-well plate and
fresh media was added. The cells were incubated for 24 h. Aer
this time the level of apoptosis was measured using a caspase-3
assay. Aer 24 h, the supernatant was removed and detached
using trypsin. The cell suspensions were centrifuged for 10
minutes at 250 g. The supernatant was removed and 25 mL of cold
lysis buﬀer was added to the cell pellet. Caspase-3 substrate (5 mL,
Ac-DEVD-pNA) was added to the samples before transferring to
a 96-well plate. The plate was incubated at 37 C for 1 h before
absorbance measurement at 405 nm. Apoptosis levels were
measured in relation to control cells with no nanoparticles.
2.10 Imaging of cellular topography aer laser irradiation
using atomic force microscopy
BxPC-3 cells were seeded into 6-well plates (50 000 cells per well)
containing quartz coverslips (Alfa Aesar, USA) and incubated at
37 C with 5% CO2. HNPs (5 mg mL
1 & 50 mg mL1) were
incubated with the cells for 24 h. Cells were washed with
phosphate buﬀered saline (PBS) four times and the coverslipsThis journal is © The Royal Society of Chemistry 2016removed from the plate. The cells were irradiated at 1064 nm as
previously described. Aer irradiation the coverslips were
returned to the 6-well plates and fresh media was added. The
cells were incubated for 24 h. Aer this time the media was
removed and cells washed four times with PBS. The cells were
xed using 2.5% glutaraldehyde in PBS for 10 min. Fixed cells
were washed ve times with PBS and mounted on glass slides.
Cell topography was imaged using a Bruker Catalyst Atomic
Force Microscope (Bruker, Germany) using Scan Asyst Adaptive
Mode. Cell membrane topography was imaged using a Scan
Asyst in Air tip of spring constant 0.4 N m1, carrying out 896
scans per line at a scan rate of 0.32 Hz and 1.102 V amplitude.
Cell membrane roughness was measured using the topog-
raphy images with Nanoscope Analysis soware (Bruker, Ger-
many). Small areas (1000  1000 nm) were chosen at random
on ten areas of each cell and their membrane roughness
determined. An average was calculated from a total of thirty
areas from three cells.
2.11 In situmeasurement and imaging of tumour heating in
pancreatic xenogra models
Female Nu/Nu mice, ve weeks of age (n ¼ 3), (Charles River,
UK) were kept in pathogen-free conditions (weight of mice was
20–25 g). All procedures and animal care were carried out
according to Project License PPL 70/8806 granted by the UK
Home Oﬃce. Human pancreatic cancer cell line BxPC-3 was
cultured to 90% conuence in RPMI 1640 supplemented with
10% fetal bovine serum and 1% penicillin streptomycin. The
cells were washed twice with cold PBS and harvested with
trypsin for 10 min at 37 C. The cells were washed three times
with PBS and resuspended in 50 : 50 media : PBS. The tumour
cell suspension (3.0  106 cells in 100 mL of 50 : 50 PBS : media)
was injected subcutaneously (s.c.) in the right ank of each
mouse. When the tumour became palpable (approximately aer
one week), measurements in two dimensions with vernier
calipers were carried out twice a week and volume tumours
calculated according to eqn (2).
V ¼ 4/3p[(D1 + D2)/4]3 (2)
Once tumour volume reached a maximum of 0.9 cm3 the
mice were sacriced and used for imaging immediately post
mortem. HNP solution (0.2 mg kg1, 100 mL) was injected
intratumorally (I.T.) using a 26 gauge needle (Vet-Tech, UK). The
tumour was irradiated at 1064 nm as previously described for 60
seconds and temperature change & heat dissipation measured
using an Optris PI640 Thermal Imaging Camera (Optris, Ger-
many). The DT data was calculated in relation to a tumour
bearing mouse aer irradiation with no nanoparticles (only
PBS) injected I.T. as per eqn (1).
3. Results and discussion
3.1 Imaging of HNPs using transmission electron
microscopy
In this work HNPs composed of an iron oxide core surrounded
by a gold shell with attached PEG were used. The HNPs wereRSC Adv., 2016, 6, 95044–95054 | 95047
Fig. 1 Characterisation of HNPs (A) size and morphology carried out
using transmission electron microscopy (TEM) & cellular uptake in
BxPC-3 cells after 24 h incubation carried out using (B) inductively
coupled plasma-optical emission spectroscopy (n ¼ 3  SD) and (C)
TEM after incubation with 5 mg mL1 and 50 mg mL1.
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View Article Onlinespherical in shape and 50 nm (5 nm, n¼ 25) as observed using
TEM (Fig. 1A). The synthetic pathway was monitored using zeta
potential measurement, UV-Vis spectrometry and the mass
composition ratio of the HNPs was quantied by inductively
coupled plasma-optical emission spectroscopy and calculated
to be 1 : 0.3 : 0.16 (Fe : Au : PEG) as previously described.13 All
subsequent concentrations quoted will be based on Fe content
of the HNPs.3.2 Cellular uptake of HNPs into BxPC-3 cells
The nanoparticles were incubated with BxPC-3 cells and their
cellular uptake measured using ICP-OES. Here the Fe content of
the cells was representative of HNP uptake and compared with
the physiologically present Fe in control cells. Fig. 1B shows that
cellular uptake of the HNPs was concentration dependent with
the 50 mg mL1 sample internalizing 6.9-fold more Fe per cell
than the 5 mg mL1 sample. These ndings were in agreement
with the TEM images showing HNP uptake (Fig. 1C1 and 2)
where more HNPs were observed in the cells incubated with
higher concentrations.3.3 Cellular response to HNP exposure
In order for HNPs to be a clinically viable platform for thera-
nostics or drug carriers, they must themselves be relatively non-
cytotoxic. In order to investigate the cellular response aer
exposure and internalization of these particles the cell
membrane integrity and cytotoxicity was measured over a 72 h
period. Cell membrane integrity was estimated via quantication
of LDH release from cells. The data showed that over the 72 h
study no signicant release of LDH was detected in comparison
to the untreated control cells up to 500 mg mL1 (Fig. 2A). This
suggested that the cell membrane had not been compromised95048 | RSC Adv., 2016, 6, 95044–95054upon exposure to the nanoparticles and that nanoparticle uptake
was not driven by membrane permeation. It is reported that for
the majority of nanoparticles, uptake is driven by endocy-
tosis.24–26 In this work endocytosis is the most likely uptake
mechanism as the TEM image (Fig. 1C2) shows nanoparticle
accumulation inside what appears to be an endosome under
formation. This nding is in agreement with previous more
in depth studies regarding cellular uptake of similar HNP
structures.13
Cell viability was measured using trypan blue exclusion
where a live/dead cell count was measured (Fig. 2B). This study
indicated that cytotoxicity was both time and concentration
dependent. The data suggested that up to concentrations of 100
mg mL1 no signicant reduction on cell viability was experi-
enced up to 48 h (p > 0.01 although at 72 h a non-signicant
reduction was evident above 25 mg mL1). At the highest
concentration tested (500 mg mL1) a signicant decrease in cell
viability was observed aer only 1 h with 80% cell viability (p <
0.01), however, the viability did not further decrease over time.
Both the cell membrane integrity and the cytotoxicity studies
indicated that at 5 mg mL1 and 50 mg mL1, no signicant
adverse eﬀect to the cells would be experienced due to the
presence or internalization of the HNPs.3.4 Investigation into heat generation and dissipation of
HNPs in vitro
Evaluation into the extent of thermal rise experienced in vitro
aer irradiation of HNPs inside BxPC-3 cells was carried out.
The measurements theoretically should give a better indication
of potential of the HNPs to act as nano-heaters in biomedicine
compared with studies carried out in phantoms. The cells were
grown on quartz to ensure no heating eﬀect was experienced
due to laser absorption of the coverslips, which would have
occurred with glass. The cells were then incubated with HNPs of
5 mg mL1 & 50 mg mL1 for 24 h to mimic the cellular uptake
quantications studies. The cells were irradiated using 1064 nm
laser light, as previously described13 the UV-Vis absorbance
for these particles is very broad with a lmax of 670 nm. Howe-
ver, irradiation is achievable at 1064 nm due to this broad
absorbance. Pulsed laser systems operating at 1064 nm are
commonly utilized in the cosmetics and ophthalmic industries
and hence these systems are reliable and relatively inexpensive.
This is an important factor in the translation of such therapies
into the clinic. Aer irradiation, our data showed that at the
lower incubation concentration (5 mg mL1), no major heating
eﬀect was experienced with a DT of 0.5 C aer 60 seconds
(Fig. 3A). However, at the higher concentration of 50 mg mL1
the HNPs did experience localised heating resulting in a bulk
DT of approximately 9 C aer the full irradiation time. In
contrast to previous work using HNPs suspended in agar
phantoms, the thermal rise prole looked remarkably
diﬀerent.21 Previously we found that the HNPs heated up rapidly
reaching their maximum temperature (40 C, 50 mg mL1)
within the rst 10 seconds aer which a plateau was reached.
However, in this study the HNPs appeared to undergo
a continual heating prole with their maximum achievableThis journal is © The Royal Society of Chemistry 2016
Fig. 2 Cellular response of BxPC-3 cells after incubation with HNPs (0–500 mgmL1) over 72 h. (A) Cell membrane integrity measured via lactate
dehydrogenase level & (B) cytotoxicity measured by trypan blue exclusion. All data quoted in relation to control cells (n ¼ 3  SD). * denotes
signiﬁcant reduction in viability compared with control sample (p < 0.01).
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View Article Onlinetemperature being more than 4-fold less reached aer the full
60 seconds of irradiation. This could be due to the fact that the
concentrations used in this study are much reduced (not all
HNPs incubated become internalised and some will be washed
away), by the fact that they are existing in a diﬀerent, more
complex media (presence salts, pH's etc.) or that the heat
capacity and ability to dissipate heat inside cells diﬀers from the
agar phantoms. In fact, when looking at the cellular uptake
study, the concentration of Fe internalised aer incubation with
50 mg mL1 was approximately 26 pg per cell. Looking at the
lower concentration incubation (5 mg mL1), the uptake ach-
ieved was approximately 5 pg per cell. This shows that there is
a non-linear relationship in the cell internalisation of the
particles. Aer internalisation the cells were estimated to be in
the magnitude of 106 in the wells. Hence, it appears that the
majority of the HNPs were internalised at the lower concentra-
tion incubation. However, at the higher concentration,Fig. 3 Eﬀect of in vitro laser irradiation of HNPs (5 mg mL1 & 50 mg mL1
(B) heat dissipation away from laser focal point measured using a therma
over multiple irradiation cycles.
This journal is © The Royal Society of Chemistry 2016approximately 50% of total HNPs have been internalised, this is
probably the major factor in the diﬀerence between phantom
and in vitro thermal rise temperatures.
The heat dissipation from the laser focal point was deter-
mined aer 60 seconds irradiation. Fig. 3B shows the heat
dissipation prole for 50 mg mL1 HNPs incubated in the cells,
where a thermal rise was observed aer 60 seconds irradiation
as far as 10 mm either side of the irradiation point, thus making
the total area experiencing a thermal increase 346 mm2. Inter-
estingly, in the phantom studies the heat dissipation at 50 mg
mL1 was detectable using an identical measurement tech-
nique at distances only up to 6 mm away from the irradiation
point with a total area thermally eﬀected of only 133 mm2. The
increase in heat dissipation shown in the in vitro experiments
may give rise to the exponential DT prole of Fig. 3A. If the
irradiation area is dissipating the heat to a greater surrounding
area then the HNPs may be losing heat more rapidly and the) in BxPC-3 cells determined by (A) thermal rise at irradiation point and
l imaging camera (n ¼ 3  SD) and (C) temperature of irradiation point
RSC Adv., 2016, 6, 95044–95054 | 95049
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View Article Onlinemaximum possible heating temperature for this concentration
may not have been reached within the 60 second period and
hence no plateau observed.
The eﬀect of multiple irradiation cycles on the heating of
HNPs was evaluated using cycles of 60 seconds irradiation fol-
lowed by 60 seconds rest. This pattern was repeated over 5 cycles
to a total of 600 seconds (10 minutes). The heating pattern
shown in Fig. 3C shows that the heat generation from laser
irradiation using these HNPs was consistent with identical
heating and cooling proles across the timeframe. This indi-
cated that the heat generation did not result in any adverse
eﬀects such as damage to the structural integrity of the particles
as this undoubtedly would have resulted in a shi in the heating
prole.
3.5 Measurement of HSP27 & HSP70 production aer laser
irradiation
It is important if HNPs are to progress further into clinical
applications, that the eﬀect they induce on cells aer irradiation
is understood. The HNPs themselves have shown no signicant
toxicity or impairment to the membrane integrity at the two
concentrations over the time period being tested (5 mg mL1 &
50 mg mL1) as shown in Fig. 2. For application as theranostics
or drug carriers in cancer therapy, the heat induced by the HNPs
can be harnessed for either tumour ablation, or as a drug
release stimuli or indeed a dual platform for both. In this case,
it is important to identify how these short sharp irradiations
may impact on the cellular state. Hence the production of heatFig. 4 Cellular response after laser irradiation of HNPs (5 mg mL1 & 50
shock protein production (A) HSP27 and (B) HSP70 24 h post 60 second i
and (D) apoptosis detection via caspase-3 enzymatic activity measuremen
(, cells incubated with HNPs experiencing no laser irradiation). * denote
denotes signiﬁcant reduction in viability compared with control sample
control cells (p < 0.01).
95050 | RSC Adv., 2016, 6, 95044–95054shock proteins (HSPs) was monitored. HSPs are upregulated in
response to stress such as temperature changes and exposure to
UV radiation. Cells produce HSPs to try and protect themselves
from any irreversible damage arising from the stress factor,27
however some studies have suggested that HSPs may aid
chemotherapies by acting as chaperones to ensure the drugs
reach their desired site in the cell.28
For pancreatic adenocarcinoma it is reported that the main
HSPs produced aer the cells experience thermal increase are
HSP27 and HSP70. The measurement of HSP27 with and
without irradiation was compared with control cells without
irradiation (Fig. 4A). Control cells with no particles were also
irradiated with no deviation in temperature or heat shock
protein production. The data suggested that the cells incubated
with 5 mg mL1 HNPs did not result in any signicant increase
in HSP27 production aer 24 h (p > 0.01). This was not unex-
pected as the DT prole at this concentration did not show any
notable thermal rise aer irradiation. However, at 50 mg mL1
the cells which had been irradiated showed an increase in
HSP27 production up to 130% compared with the cells experi-
encing no irradiation (p < 0.01).
Similarly the ELISA for measuring HSP70 (Fig. 4B) showed no
signicant increase in HSP70 aer irradiation with 5 mg mL1
HNPS but 135% production was observed at 50 mg mL1 (p <
0.01). These ndings show that whilst the total irradiation time
of the cells was only 60 seconds and the DT was a relatively
modest 9 C compared with previous phantom studies, this was
still enough to induce cellular stress.mg mL1) in BxPC-3 cells determined by ELISA measurement of heat
rradiation. (C) measurement of cell viability using trypan blue exclusion
t 24 h post- 60 second andmultiple- irradiation cycles (n¼ 3 SD)
s signiﬁcant increase in HSP production compared to control cells, **
, *** denotes signiﬁcant increase in caspase-3 activity compared with
This journal is © The Royal Society of Chemistry 2016
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View Article Online3.6 Cell viability aer laser irradiation
The cell viability was measured 24 h aer laser irradiation of
cells incubated with 5 mg mL1 & 50 mg mL1 HNPS in order to
determine if the heat produced resulted in adverse eﬀects
resulting in cell death. Fig. 4C shows the % viability of the
treated cells with and without laser irradiation compared with
untreated control cells. Here the data is in line with the HSP
production. Whereby, at 5 mg mL1 HNP incubation and
irradiation, no adverse eﬀect was observed on cell viability.
However, a small reduction in viability aer 60 seconds laser
irradiation was observed at 50 mg mL1 HNP incubation and
irradiation with 85% of cells being viable aer the 24 h period
(p < 0.01). Interestingly, the cells did not experience any major
reduction in cell viability aer multiple irradiation cycles
compared with the single irradiation samples. This indicates
that the cells could be multiply irradiated with little eﬀect to
cells and that the temperature itself is the only contributing
factor to the cellular fate and not the duration of the cycles. In
the case of this study, therefore, the HSPs produced may beFig. 5 Eﬀect of HNP irradiation on BxPC-3 cell topographymeasured usi
cells incubated with 5 mgmL1 HNPs & (3) cells incubated with 50 mgmL
multiple irradiation cycles. Cells were ﬁxed 24 h post irradiation and imag
from topography images and analysed using NanoScope Analysis softw
irradiation, and- multiple irradiation cycles. * denotes a signiﬁcant incr
This journal is © The Royal Society of Chemistry 2016adequate enough to allow recovery of cells and hence ablation
is not achieved.3.7 Detection of apoptosis via measurement of caspase-3
activity aer laser irradiation
Caspase-3 activity was measured as an indication of the
apoptotic state of the cells (Fig. 4D). In line with the cell
viability, those cells which underwent laser irradiation aer
incubation with 5 mg mL1 HNPs did not experience a signi-
cant increase in caspase-3 activity. This indicated that the cells
were in a healthy state and were not undergoing apoptosis. In
contrast, those cells which were incubated with 50 mg mL1
HNPs did possess signicant caspase-3 activity with a 5%
increase compared with the controls. These ndings were in
agreement with the heat shock protein production at higher
HNP concentrations aer laser ablation. In common with the
cytotoxicity, the caspase-3 levels did not increase with
increasing irradiation cycles, and hence it can be further
conrmed that the temperature alone was suﬃcient to initiateng atomic forcemicroscopy. Topography imaged in (1) control cells, (2)
1 HNPs both (A) untreated and (B) irradiated for 60 seconds and (C) after
ed using Scan Asyst Adaptive Mode. (D) Roughness analysis carried out
are (n ¼ 3  SE). , cells experiencing no irradiation, - 60 seconds
ease compared to control cells (p < 0.01).
RSC Adv., 2016, 6, 95044–95054 | 95051
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View Article Onlinethe changes to cellular state and not necessarily the duration of
irradiation.3.8 Imaging of cellular topography aer laser irradiation
using atomic force microscopy
In order to further investigate the cellular response aer laser
irradiation of the HNPs the cellular topography was imaged
using AFM (Fig. 5). Here the cells were xed aer 24 h post
irradiation. The images showed (Fig. 5B2) that cellular
morphology was not altered aer 60 seconds laser irradiation of
HNPs incubated at 5 mg mL1 compared with the control cells
and those with HNPs without irradiation (Fig. 5A1 and B1
respectively). However, in comparison to the control cells
(Fig. 5B3) the cells incubated with HNPs at 50 mg mL1 did have
an eﬀect on morphology. Here the cells appeared a little
rougher and atter compared to the control sample, and the
cells incubated with HNPs without irradiation and (Fig. 5A1 and
B1 respectively). Although the cell viability assays indicated only
slight reduction in viability was observed, the AFM images
indicate that the cells have undergone some alteration
compared with their normal state as a consequence of laser
irradiation of the internalised HNPs. However, this did not
appear to be exacerbated further upon multiple irradiation
cycles, with the cells (Fig. 5C3) looking similar to the single
irradiation cells.Fig. 6 Eﬀect of in situ laser irradiation of HNPs injected I.T. in pancreatic
(B & C) heat dissipationmaps of tumours absent (B) and with 50 mgmL1 H
(1) thermal rise at irradiation point and (2) heat dissipation away from las
95052 | RSC Adv., 2016, 6, 95044–95054Cell roughness analysis was carried out on the topography
images obtained. The data (Fig. 5D) indicated that the cells
experiencing the laser irradiation with 50 mg mL1 HNPs
possessed signicant increase in membrane roughness
compared to the control cells, in agreement with the visual
images.3.9 In situ measurement and imaging of tumour heating in
pancreatic xenogra models
The in vitro studies conrmed that once under physiological
conditions and at concentrations which may be clinically rele-
vant, the HNPs exhibited diﬀerent thermal behavior to previous
gel phantom studies. To further elucidate the heating potential
inside biological systems the HNPs were irradiated aer I.T.
injection into subcutaneous xenogra pancreatic tumours,
volume ¼ 0.9 cm3 (Fig. 6A) immediately postmortem and
imaged using the thermal camera. Fig. 6 shows the heating
eﬀect on the tumour tissue aer 60 seconds irradiation. In the
control mouse, no tissue heating eﬀect was observed at the
irradiation site (Fig. 6B1–3). In contrast the mouse with HNPs
injected I.T. showed localized heated at the laser irradiation
point which spread to the entire tumour over the 60 second
period. Interestingly, the tumour tissue achieved DT of up to 10
C which is an increase compared to the in vitro studies
(although not signicant p > 0.01) (Fig. 6D1). However, thexenograft models. (A) Nu/Nu xenograft (BxPC-3) tumor bearing mouse,
NPs I.T. (C) at (1) t¼ 0 s, (2) t¼ 30 s and (3) t¼ 60 s. (D) Quantiﬁcation of
er focal point measured using a thermal imaging camera (n ¼ 3  SD).
This journal is © The Royal Society of Chemistry 2016
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View Article Onlineheating prole was similar to the agar phantom studies, this
perhaps indicated when the HNPs are in more conned areas
that their thermal eﬃciency increases. The fascinating images
show that the heat spread or dissipation is conned to the three
dimensional tumour structure and does not appear to have
dissipated through to the main anatomy of the mouse. In
common with the in vitro studies (and contrast to the phantom
studies) the HNP irradiation resulted in a thermal increase
which could be detected up to 11 mm in each direction from the
laser focal point – tumour measurements (11.9 mm  11 mm).
This resulted in an irradiation area of 491 mm2 (Fig. 6D2). Aer
irradiation, the tumours were re-measured to see whether
heating of the HNPs had any eﬀect on total tumour volume.
This study showed that no diﬀerence in tumour volume was
experienced aer irradiation and that average tumour volume
was 0.9 cm3. The relatively increased area experiencing heat
dissipation compared to the agar samples indicates that these
phantoms may act as indicators of heating potential, but do not
indicate in vivo fate.4. Conclusion
With the ndings from this work it can be concluded that the
HNPs are capable of acting as nano-heaters aer laser irradia-
tion at 1064 nm at 50 mg mL1, which appeared to be an
applicable concentration clinically as the particles were well
tolerated by the cells. The lower concentration of 5 mg mL1 did
not appear to be eﬀective for nano-heating applications, prob-
ably because the particles were too far apart spatially in order
for their gold shell heating to adequately cause any major
increase in bulk temperature. The production of heat shock
proteins in the 50 mg mL1 HNP irradiation sample indicated
that the short duration of irradiation and spike in temperature
was adequate to result in cellular stress and this must be taken
into account when designing these particles for future appli-
cation. In this study the cells were incubated at 37 C and a DT
of 9 C resulting in temperatures up to 46 C. Indeed, there was
a small eﬀect on cell viability aer irradiation, however, for
application in tumour ablation either the irradiation period
would need to be extended or the HNP concentration increased
to induce a great enough stress on cells resulting in pro-
grammed cell death. This correlates with previous studies
where they have stated that temperatures as high as 50 C are
required for irreversible cellular damage to occur. However, in
vivo it has been reported that cancerous tissue exists at higher
temperatures than normal body tissue with temperatures as
high as 44 C, therefore, these HNPs may be suﬃcient in
reaching temperatures of up to 53 C causing ablation.
However, this is yet to be explored. As such, it is suggested that
the HNPs in this form (size, morphology, concentration) may be
useful in theranostic systems whereby MRI guidance is inferred
from the magnetic iron oxide core as well as the heat harnessed
from laser irradiation for stimuli responsive drug release. It is
postulated that the combined use of drug therapy and in vitro/in
vivo heating will result in a synergistic eﬀect resulting in a more
eﬃcient rate of kill. This work is currently being investigated.This journal is © The Royal Society of Chemistry 2016Conﬂict of interest
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